Harvard

Recent shortages of the type 2 diabetes therapies semaglutide and tirzepatide, widely reported in the consumer press, appear to be resolving, according to manufacturers and prescribers.

Patients with hematologic malignancies reported significant improvement in quality of life after receiving chimeric antigen receptor T cells, results from a longitudinal study in Blood Advances showed.

An analysis of administrative claims data across six high-income countries shows income disparities in treatments and outcomes persist for older adults after acute MI, including countries with universal health insurance.

Being younger at menopause onset and initiating hormone therapy after more than 5 years were both linked to increased tau vulnerability among women, according to a cross-sectional study published in JAMA Neurology.

The concept of food addiction is a hotly debated one.

An analysis of individuals in the United States with public insurance showed that those with sickle cell disease died more than 20 years earlier than the average person.

Despite an overall positive safety outlook, the scope of potential toxicities related to chimeric antigen receptor T-cell therapy remains unclear due to lack of long-term follow-up.

Mothers who contract COVID-19 during pregnancy are more likely to have infants with a lower birth weight and greater weight gain during the first year of life compared with mothers who did not have COVID-19, according to study data.

Patients with autoimmune rheumatic disease who receive outpatient therapy are 88% less likely to develop severe COVID-19 outcomes vs. with those who do not undergo outpatient therapy, according to data published in The Lancet Rheumatology.

Providers should tailor approaches to hypertension care, including self-care and treatment intensification, to improve hypertension management for patients from underrepresented racial and ethnic populations, according to researchers.